Previous 10 | Next 10 |
Company expects to achieve $45-$50 million in annualized operating expense savings in fiscal 2025 Management to discuss first quarter 2024 financial results, restructuring and strategic initiatives on May 8, 2024 conference call SOUTH SAN FRANCISCO, Calif., April 25, 2024 (GLO...
TORONTO, April 22, 2024 (GLOBE NEWSWIRE) -- Labrador Gold Corp. (TSX.V:LAB | OTCQX:NKOSF | FNR: 2N6) (“ LabGold ” or the “ Company ”) is pleased to announce that it has entered into a property purchase agreement (the “ Definitive Agreement ”) ...
TORONTO, April 17, 2024 (GLOBE NEWSWIRE) -- Labrador Gold Corp. (TSX.V:LAB | OTCQX:NKOSF | FNR: 2N6) (“LabGold” or the “Company”) is pleased to announce the completion and filing of an independent technical report ("NI43-101 Report") prepared in accordance with Nationa...
SOUTH SAN FRANCISCO, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health™ – today announced the introduction of new solutions that add automation and flexibilit...
2024-04-03 16:10:28 ET More on Standard BioTools Standard BioTools Inc. (LAB) Q4 2023 Earnings Call Transcript Standard BioTools exchanges all outstanding Series B convertible preferred stock for common stock Standard BioTools expects over 10% growth in 2023 core rev...
SOUTH SAN FRANCISCO, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health™ – today announced that it has entered into a multi-year engagement with glob...
2024-03-27 17:08:02 ET CEO of Labrador Gold, Roger Moss, talks about potential high-grade gold discoveries in Newfoundland Labrador Gold 's main focus is gold exploration in Eastern Canada. Overall, the company has 4 projects, 1 in Ontario, 2 in Labrador; and more recently an ...
2024-03-27 17:08:02 ET Potential for high-grade gold discoveries at its project in Newfoundland Labrador Gold is a Canadian based mineral exploration company. They're focusing on the acquisition and exploration of prospective gold projects in Eastern Canada. In early March 202...
2024-03-20 04:33:40 ET Summary Cytek Biosciences is a leading cellular analysis instrument maker with a focus on the Aurora flow cytometry platform. Despite a downturn in the healthcare market, Cytek has maintained revenue growth above 15% since IPO. Cytek's technological adva...
2024-03-18 09:37:53 ET More on Standard BioTools Standard BioTools Inc. (LAB) Q4 2023 Earnings Call Transcript Standard BioTools expects over 10% growth in 2023 core revenue Standard BioTools, SomaLogic fall after shareholder nod for merger Seeking Alpha ...
News, Short Squeeze, Breakout and More Instantly...
Standard BioTools Inc. Company Name:
LAB Stock Symbol:
NASDAQ Market:
Standard BioTools Inc. Website:
SOUTH SAN FRANCISCO, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB) today announced that it will report second quarter 2024 financial results on Wednesday, July 31, 2024, after the close of the...
TORONTO, July 09, 2024 (GLOBE NEWSWIRE) -- Labrador Gold Corp. (TSX.V:LAB | OTCQX:NKOSF | FNR: 2N6) (“ LabGold ” or the “ Company ”) is pleased to announce that, further to its Press Release dated June 27, 2024, the Company has successfully completed its sale t...
SOUTH SAN FRANCISCO, Calif and SALT LAKE CITY, May 28, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB) today announced that it has purchased the LSA XT system from Carterra ® , a leading provider of high-throughput large and small molecule screening and characteriza...